Evaluation of Shatyadi churna in patients having symptoms of Tamak Shwasa (bronchial asthma)

Phase 2

• Conditions: Health Condition 1: J459- Other and unspecified asthma

• Registration Number: CTRI/2023/07/054942
• Lead Sponsor: ttarakhand Ayurved University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Pinasa 2.Ghurghurak 3.kasa

4. Kantodhvansa 5.Vak kricchrata 6.Lalat Sweda

7.Parshvagraha 8.Ushnabhiprayata 9.Aasya Shushkata

10.Vepathu 11.Aruchi 12.Annadvesh

Mild intermittent, mild persistent, moderate persistent asthma according to global initiative

for asthma (GINA) guidelines.

Blood Oxygen saturation (spO2) >90%.

PEFR >100 litre/min.

Age 20-60 years

Exclusion Criteria

Severe persistent asthma according to global initiative for asthma (GINA) guidelines

H/O Tuberculosis, COPD, Emphysema, Other complicated respiratory diseases.

Known case of Hypertension and cardiac involvement and any other serious illness.

PEFR < 100 litre/min.

Blood Oxygen saturation (spO2 < 90%)

H/O Endocrine disorders like Diabetes mellitus.

Patients with frequent H/O hospitalization due to Status Asthmaticus.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of Shwasa Vega <br/ ><br>Intensity & duration of attack <br/ ><br>Need of emergency medicine if <br/ ><br>required <br/ ><br>Shwasakrichhrata <br/ ><br>Kasa <br/ ><br>Ghurghurukam <br/ ><br>Pinasa <br/ ><br>Parshva Shula <br/ ><br>Kapha Nishthivana <br/ ><br>Asino Labhate Saukhyam <br/ ><br>Kanthodhwansan <br/ ><br>Sleshma Vimokshante Labhate Sukham <br/ ><br>Anidra <br/ ><br>Ushnabhinanditi <br/ ><br>VisushkasyataTimepoint: outcome will be evaluated every 10th day for 30 days

Secondary Outcome Measures

Name	Time	Method
PEFR <br/ ><br>Percentage of oxygen saturation <br/ ><br>chest expansion <br/ ><br>Erythrocyte sedimentation rate <br/ ><br>absolute eosinophil countTimepoint: outcome will be evaluated every 10th day for 30 days